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Abstract
Background: Bacteriophage replication depends on bacterial proteins and inactivation of genes coding for
such host factors should interfere with phage infection. To gain further insights into the interactions between
S. pneumoniae and its pneumophages, we characterized S. pneumoniae mutants selected for resistance to the
virulent phages SOCP or Dp-1.
Results: S. pneumoniae R6-SOCPR and R6-DP1R were highly resistant to the phage used for their selection
and no cross-resistance between the two phages was detected. Adsorption of SOCP to R6-SOCPR was partly
reduced whereas no difference in Dp-1 adsorption was noted on R6-DP1R. The replication of SOCP was completely
inhibited in R6-SOCPR while Dp-1 was severely impaired in R6-DP1R. Genome sequencing identified 8 and 2 genes
mutated in R6-SOCPR and R6-DP1R, respectively. Resistance reconstruction in phage-sensitive S. pneumoniae
confirmed that mutations in a GntR-type regulator, in a glycerophosphoryl phosphodiesterase and in a Mur
ligase were responsible for resistance to SOCP. The three mutations were additive to increase resistance to
SOCP. In contrast, resistance to Dp-1 in R6-DP1R resulted from mutations in a unique gene coding for a type
IV restriction endonuclease.
Conclusion: The characterization of mutations conferring resistance to pneumophages highlighted that
diverse host genes are involved in the replication of phages from different families.
Keywords: Streptococcus pneumoniae, Bacteriophage, Resistance, Whole genome sequencing, GntR regulator
Background
Streptococcus pneumoniae is an opportunistic colonizer
of the nasopharynx and the causative agent of many serious
diseases such as pneumonia, sepsis, meningitis and otitis
media. Initially, strains of S. pneumoniae were exquisitely
susceptible to penicillin, and β-lactam antibiotics were the
recommended empirical treatment against pneumococcal
diseases. However, pneumococci resistant to β-lactams and
other classes of antibiotics now represent a major burden
due to the spread of multidrug resistant clones [1–3] and
penicillin-resistant pneumococci are listed among the most
serious antibiotic resistance threats [4]. Antimicrobial re-
sistance will require innovation not only in the develop-
ment of new antibiotics but also in alternative treatment
strategies and, in this context, biological therapeutics were
included among the seven key areas of antimicrobial resist-
ance for which research is urgently needed [5].
Bacteriophage (phage) therapy represents one of the
promising alternatives against multidrug resistant patho-
gens. Strategies include the use of isolated virions but
also some of their products like endolysins, a family of
peptidoglycan hydrolases released at the terminal stage
of phages replication cycle for the lysis of infected cells
and phage progeny release. In the case of S. pneumoniae,
a number of studies have demonstrated the potential of
phage-produced endolysins against otitis media [6],
bacteremia [7] and pneumonia [8, 9]. In contrast, while
pneumophages have been repeatedly described in the lit-
erature [10–18], studies evaluating the use of whole
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virions have lagged behind. A high proportion of S.
pneumoniae clinical isolates are lysogens [19–21] and
the vast majority of pneumophages currently identified
are temperate phages. However, because temperate
phages have the ability to transfer host DNA and/or in-
crease virulence [22], virulent phages are thought to be
better suited for biocontrol purposes.
Very few virulent bacteriophages infecting S. pneumo-
niae have been isolated. Despite the isolation of Omega
phages several decades ago [18], the pneumophages
Dp-1 and Cp-1 are the only lytic phages that remain
available in curated bacteriophage collections. Phage
Dp-1 was the first virulent pneumophage to be isolated
[12]. It belongs to the Siphoviridae family and has a
DNA genome of 56,506 bp coding for 72 putative pro-
teins, 39 of which could be annotated based on se-
quence homology [23]. Phage Cp-1 was isolated in
1981 [16] and is a member of the Podoviridae family.
Its DNA genome of 19,345 bp contains 25 open reading
frames >50 nucleotides of which a third could be
assigned a function based on sequence homology at the
protein level with gene products from bacteriophage
phi29 infecting Bacillus subtilis [24]. The infectivity of
Dp-1 and Cp-1 was shown to require choline in the
pneumococcus cell wall [12]. More recently, a natural
variant of Cp-1 called SOCP with a genome of 19,347
bp and 31 single nucleotide variations has been de-
scribed [25]. The annotation of the genome of SOCP
revealed 27 open reading frames, each preceded by a
putative ribosome-binding site, and a putative function
could be assigned to 12 proteins [25].
One of the perceived drawbacks of phage therapy is
the likely emergence of phage-resistant derivatives or
clones [26]. Such phage resistance phenotype may be
due to dedicated defense mechanisms harboured by
some strains, including restriction-modification systems
and CRISPR-Cas systems or may be due to the absence
of specific host factors such as phage receptors or to the
presence of interfering capsular polysaccharides [27]. In
addition to phage adsorption at the cell surface, many
other steps of the phages lytic cycle such as replication,
transcription and translation also likely depend on bacter-
ial cytoplasmic gene products. The absence or inactivation
of some of these genes could prevent the lysis of phage-
infected cells. Therefore, an in-depth understanding of the
bacterial factors involved in phage-host interactions is
needed to optimize the selection of appropriate thera-
peutic phage.
Here, we identified host factors involved in the pneu-
mophage infection process. We first confirmed, using
molecular tools, the role of the capsule in protecting
pneumophage infection. We also infected the unencapsu-
lated S. pneumoniae R6 with virulent phage Dp-1 and
SOCP and selected spontaneous bacteriophage-insensitive
mutants. Genome sequencing of the mutants and func-
tional analysis revealed diverse mutations implicated in re-
sistance to pneumophages.
Results
Interaction of bacteriophages SOCP and DP-1 with S.
pneumoniae
The unencapsulated strain S. pneumoniae R6 is highly
sensitive to pneumophages SOCP and Dp-1 (Table 1).
This is in sharp contrast to its encapsulated S. pneumo-
niae D39 ancestor which demonstrates complete resist-
ance (Table 1). The pneumococcal capsule had previously
been shown to inhibit infection by omega pneumophages
[27] and it is possible that a similar protective role also
occur against bacteriophages SOCP and Dp-1. The role of
the pneumococcal capsule in the resistance to phages
SOCP and Dp-1 was assessed by generating a S. pneumo-
niae D39 derivative inactivated for the gene cps2C
(SPD_0317). The inactivation of cps2C was previously
shown to result in a severe reduction in capsule size [28].
Capsular serotyping with an antisera directed against type
2 pneumococcal capsular polysaccharides confirmed the
Table 1 Sensitivity of S. pneumoniae strains to bacteriophages SOCP and Dp-1
S. pneumoniae strains cps2C statusa Capsuleb Phages
SOCP Dp-1
Phage titer (PFU/mL) EOPc Phage titer (PFU/mL) EOPc
R6 NA - 109 1 1010 1
D39 WT + 0 NA 0 NA
D39Δcps2C KO - 109 1 1010 1
D39cps2C-rspL WT + 0 NA 0 NA
R6-SOCPR NA - 1 10−9 1010 1
R6-DP1R NA - 109 1 102 10−8
aWT, S. pneumoniae D39 wild type allele; KO, S. pneumoniae D39 allele inactivated by insertion-duplication mutagenesis; NA, Not applicable since the gene is
absent in S. pneumoniae R6 due to the deletion of the capsule locus [77, 78]
b‘+’ and ‘-’ respectively indicate the presence and absence of the pneumococcal capsule as determined by the Quellung reaction (see Fig. 1)
cEOP, efficiency of plaquing. Represents the ratio of phage titers from the test strain to the indicator strain S. pneumoniae R6 WT. Measured from three
independent triplicates. NA, not applicable because of absolute bacteriophage resistance
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absence of detectable capsule in S. pneumoniae D39Δcps2C
(Fig. 1). S. pneumoniae D39Δcps2C also had the same level
of sensitivity to SOCP and Dp-1 as S. pneumoniae R6
(Table 1). Reverting cps2C to a WT version in D39Δcps2C
restored the capsule and abrogated phage sensitivity in the
resulting S. pneumoniae D39cps2C-rpsL transformant (Fig. 1
and Table 1). The pneumococcal serotype 2 capsule is
thus a major determinant of resistance against virulent
pneumophages.
To further our understanding of interactions be-
tween pneumophages and S. pneumoniae R6, we selected
bacteriophage-insensitive mutants (see Methods). One
mutant resistant to phage SOCP and another resistant to
phage Dp-1 were chosen for further characterization and
these were named S. pneumoniae R6-SOCPR and R6-
DP1R, respectively (Table 1). The bacteriophage-
insensitive mutants R6-SOCPR and R6-DP1R mutants had
unaltered growth kinetics compared to S. pneumoniae R6
wild-type (WT) (Additional file 1). Both mutants also
displayed a normal morphology under electronic micros-
copy and had unaltered cell wall thickness compared to
their S. pneumoniae R6 parent (Additional file 2). The
R6-SOCPR and R6-DP1R mutants were highly resist-
ant to the phage used for their selection. There were
no detectable plaques when a SOCP bacteriophage
suspension (109 PFU/mL) was spotted onto a lawn of
R6-SOCPR (Table 1). In contrast, spotted SOCP bac-
teriophages onto a lawn of S. pneumoniae R6 WT
resulted in a confluent zone of clearing (Table 1).
Similarly, the efficiency of plaquing (EOP) of Dp-1 on
R6-DP1R was determined to 10−8 when compared to
the indicator strain S. pneumoniae R6 (Table 1). The
mutants R6-SOCPR and R6-DP1R remained sensitive
to Dp-1 and SOCP, respectively (Table 1).
Adsorption and replication of pneumophages SOCP
and Dp-1
To gain further insights into the step of the infective
cycle that is blocked in the resistant mutants, we first
tested whether bacteriophage adsorption was prevented
in R6-SOCPR and R6-DP1R. Adsorption assays showed
that pneumophages SOCP and Dp-1 efficiently adsorbed
to S. pneumoniae R6 but that adsorption of SOCP was
reduced on mutant R6-SOCPR (Fig. 2). SOCP adsorption
levels on R6-SOCPR still remain substantially high how-
ever (Fig. 2), suggesting additional mechanisms for
resistance (Table 1). In contrast, the S. pneumoniae R6-
DP1R mutant adsorbed DP-1 bacteriophages as effi-
ciently as S. pneumoniae R6 (Fig. 2). The resistance of
both mutants thus likely affect a step of the lytic cycle
beyond the phage adsorption process.
Fig. 1 Detection of type 2 capsular polysaccharides in S. pneumoniae.
Preparations of S. pneumoniae R6 WT and S. pneumoniae D39 WT, or
from D39Δcps2C and its complemented D39cps2C-rpsL version with no
antiserum (control) and with type 2 antisera were viewed under oil
immersion using a Nikon Eclipse TE300 microscope and a 100×
objective. A positive Quellung reaction is observed when the cells
appear swollen in the presence of antisera, which is indicative
of the presence of type 2 capsular polysaccharides. The presence
and absence of the capsule is indicated by a ‘+’ and a ‘-’, respectively.
Sensitivity and resistance to pneumophages (SOCP and Dp-1) is
indicated by a ‘+’ and a ‘-’, respectively
Fig. 2 Adsorption of phages SOCP and Dp-1 on S. pneumoniae
strains. Rates of adsorption of SOCP and Dp-1 on S. pneumoniae R6
WT (black), R6-SOCPR (light grey) or R6-DP1R (dark grey). No adsorption
occurred in the absence of bacteria (empty bar). Adsorption of SOCP
on R6-DP1R and adsorption of Dp-1 on R6-SOCPR was not measured
since no bacteriophage cross-resistance occurred in the mutants (see
Table 1). ***denotes significant differences in adsorption compared to
the mock control (p < 0.0001; one-way non-parametric ANOVA).
###denotes significant differences in adsorption compared to R6
WT (p < 0.0001; one-way non-parametric ANOVA)
Leprohon et al. BMC Genomics  (2015) 16:972 Page 3 of 13
We next assayed whether the intracellular replica-
tion of pneumophages is impaired in S. pneumoniae
R6-SOCPR and R6-DP1R. Total DNA (including
chromosomal DNA and phage DNA) was extracted at
successive time points following infection of S. pneu-
moniae R6-SOCPR and R6-DP1R with phages SOCP
and Dp-1, respectively. The DNA samples were then
digested with SspI before being electrophoresed and
transferred on Nylon membrane. Hybridizing mem-
branes with probes covering the holin gene from
SOCP or Dp-1 allowed monitoring the kinetics of
phage genome replication by measuring the intensity
of phage DNA over time after infection. In S. pneu-
moniae R6, replication of SOCP was already well ad-
vanced at 15 min following infection and SOCP DNA
levels had increased by an estimated 20-fold after 90
min (Fig. 3a and f ). In contrast, no holin-derived
signals could be detected following infection of R6-
SOCPR even at the 90 min time point (Fig. 3b and f ).
This suggests that resistance in S. pneumoniae R6-
SOCPR occurs at very early stages of the infection
cycle. In our experimental conditions, the replication
of pneumophage Dp-1 within S. pneumoniae R6
began after a latency of about 30 to 45 min [29], and
after 90 min Dp-1 DNA levels had increased by an
estimated 22-fold (Fig. 4a and c). An increase in Dp-1
holin signals was also observed upon infection of S.
pneumoniae R6-DP1R but at a 4-fold decreased rate
compared to S. pneumoniae R6 (Fig. 4b-c). This
suggests that Dp-1 replication occurred but was se-
verely impaired in the R6-DP1R mutant.
Whole genome sequencing of S. pneumoniae R6-SOCPR
and R6-DP1R
Whole genome sequencing is useful for identifying
genes involved in host-phage interactions [30–32] and
the genomes of S. pneumoniae R6-SOCPR and R6-
DP1R (one clone of each) were sequenced to identify
mutations putatively implicated in resistance. Whole-
genome sequencing revealed a total of eleven and five
nucleotide mutations in the genomes of R6-SOCPR
and R6-DP1R, respectively (Table 2). None of the mu-
tations (or mutated genes) was common to both mu-
tants (Table 2) which is consistent with the absence of
cross-resistance (Table 1). Every mutation detected in
R6-SOCPR occurred within coding sequences (in eight
genes) while two of those found in R6-DP1R were
non-coding (Table 2). For both mutants, mutations in
open reading frames invariably led to amino acid sub-
stitutions (Table 2).
The role of each mutation in pneumophage resistance
was assessed by resistance construction, a strategy shown
useful for pinpointing mutations implicated in antibiotic
resistance in S. pneumoniae [33–39]. This was done by
transforming S. pneumoniae R6 WT with separate PCR
products covering variant alleles derived from R6-SOCPR
or R6-DP1R along with a PCR fragment covering the rpsL
allele of S. pneumoniae CP1250 [40] and conferring
Fig. 3 Kinetics of SOCP DNA replication. S. pneumoniae R6 WT (a), R6-SOCPR (b) and S. pneumoniae R6 transformed with R6-SOCPR-derived alleles
for genes spr0058 (c), spr0897 (d) or spr1443 (e) were infected with the lytic phage SOCP at a MOI of 0.1. Total DNA was extracted at baseline
and at 15, 30, 45, 60 and 90 min after infection. Total DNA was digested with SspI before being hybridized with an [α-32P]dCTP-labeled probe
covering the holin gene of SOCP (top blots). DNA loading was controlled by hybridizing the blots with an [α-32P]dCTP-labeled probe covering
the spr1443 gene from S. pneumoniae R6 (bottom blots). Holin/spr1443 signal ratios are indicated in italics below the blots. Hybridizations were
done in triplicates and representative blots are shown. f Plot of holin/spr1443 signal ratios for S. pneumoniae R6 WT (black), R6-SOCPR (dark grey),
R6spr0058 (dashed dark grey), R6spr0897 (dashed black), and R6spr1443 (dashed light grey). For each strain, the ratios at each time point (except for
R6spr1443 at 90 min) were significantly different (p < 0.01 by two-way ANOVA) than those of R6 WT
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resistance to streptomycin. The latter was used as a
surrogate marker for the selection of transformants.
The rpsL allele had no impact on pneumophage
susceptibility levels when transformed alone (Tables 3
and 4). The streptomycin-resistant transformants
were then screened for the presence of mutated al-
leles. Using a similar approach, the mutated genes
were reverted back to their WT versions in the R6-
SOCPR or R6-DP1R mutants for phenotype confirm-
ation. Finally, each reconstructed strain was tested
for resistance to SOCP or Dp-1.
Mutations involved in resistance to SOCP
A role in resistance to phage SOCP was confirmed for
three of the eleven mutations (in genes spr0058, spr0897
and spr1443) detected in the S. pneumoniae R6-SOCPR
mutant (Table 3). The gene spr0058 codes for a GntR-
type transcription factor and the introduction of the
spr0058 allele from R6-SOCPR into S. pneumoniae R6
WT decreased the EOP of SOCP by three orders of
magnitude (R6spr0058 in Table 3). Transforming S. pneu-
moniae R6 WT with PCR fragments covering the genes
spr0897 (coding for a glycerophosphoryl phosphodiester-
ase) or spr1443 (coding for a Mur ligase homolog) amp-
lified from S. pneumoniae R6-SOCPR similarly decreased
the EOP of SOCP by three logs (R6spr0897 and R6spr1443
in Table 3). In all cases, reverting any of the three muta-
tions in S. pneumoniae R6-SOCPR to a WT allele con-
ferred coherent sensitivity levels to phage SOCP for the
transformants R6-SOCPR_spr0058WT, R6-SOCPR_spr0897WT
and R6-SOCPR_spr1443WT (Table 3). Moreover, introdu-
cing the spr0058, spr0897 and spr1443 mutations
altogether in S. pneumoniae R6 produced transformants
as resistant to SOCP as the original R6-SOCPR mutant
(R6spr0058-0897-1443 in Table 3), although the combination
of any two mutations appears sufficient to confer high-
level resistance (Table 3). Interestingly, introducing the
spr0058, spr0897 or spr1443 mutations in S. pneumoniae
Fig. 4 Kinetics of Dp-1 DNA replication. S. pneumoniae R6 WT (a) and R6-DP1R (b) were infected with the lytic phage Dp-1 at a MOI of 0.1. Total
DNA was extracted at baseline and at 15, 30, 45, 60 and 90 min after infection. Total DNA was digested with SspI before being hybridized with
an [α-32P]dCTP-labeled probe covering the holin gene of DP-1. DNA loading was controlled by hybridizing the blots with an [α-32P]dCTP-labeled
probe covering the spr1443 gene from S. pneumoniae R6. Holin/spr1443 signal ratios are indicated in italics below the blots. Hybridizations were
done in triplicates and representative blots are shown. c Plot of holin/spr1443 signal ratios for S. pneumoniae R6 WT (black) and R6-DP1R
(dark grey). The R6-DP1R ratios from 45 to 90 min were significantly different (p < 0.001 by two-way ANOVA) than those of R6 WT
Table 2 List of all mutations identified in the genome of
R6-SOCPR and R6-DP1R
Strains Genes Function Mutationsa,b,c
R6-SOCPR spr0058 GntR-type transcription factor G460A
E154K











srp1443 Mur ligase homolog T1223C
V408A
spr1584 Hypothetical protein A1229C
Y410S
spr1777 RNA polymerase rpoB G827C
R276P
spr1923 Hypothetical protein G690C G691C
Q230H A231P
R6-DP1R spr0291 Phosphotransferase system
sugar-specific EII component
C-101G





spr1445 Dipeptidase M24 family G918A
M306I
spr1453 Major facilitator transporter T-187G
aFor each mutation, the change at the nucleotide level is indicated on top and
the corresponding substitution at the amino acid level is indicated in
italic underneath
bMutations in bold have a confirmed role in resistance
cFor mutations in intergenic regions, an hyphen in front of the mutated
position indicates the nucleotide position upstream of the ATG
dBoth mutated positions are part of the same codon and lead to a single
amino acid substitution
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R6 WT also impaired the DNA replication of SOCP
(Fig. 3c-f ), especially in the case of spr0897 (Fig. 3f ).
When additional S. pneumoniae R6 mutants made re-
sistant to SOCP were tested for the presence of muta-
tions in spr0058, spr1897 and spr1443, three (out of
four) additional mutants had a mutation in at least one
of the genes (Table 5). None of the mutants had the
exact same genotype for the three genes tested which
preclude multiple sampling of the same end-point clone
from the original culture (although divergence from a
common ancestor mutated for spr1443 cannot be ex-
cluded) (Table 5). Instead, it highlights the major role of
genes on the infective cycle of SOCP. For spr0897 and
spr1443 the mutations even targeted the same amino acid
as in the R6-SOCPR mutant, leading to a different substi-
tution in the case of spr0897 (Table 5). S. pneumoniae R6-
SOCP-5R was the only additional mutant with a mutation
in gene spr0058, harbouring a non-sense mutation at
codon 131 (Table 5). The E154K mutation originally de-
tected in spr0058 in R6-SOCPR (Table 2) is also expected
to considerably alter the activity of the protein given that
S. pneumoniae R6spr0058 harbouring the spr0058 E154K
mutation from R6-SOCPR displayed the same level of
resistance to SOCP than S. pneumoniae R6Δspr0058 in
which we inactivated spr0058 by insertion-duplication
mutagenesis (Table 3). The gene product of spr0058 has
similarity with regulators of the metabolite-responsive
GntR family, which often regulate the expression of
genes nearby of their location on the chromosome
[41]. Comparative gene expression profiling by RNA-
seq between S. pneumoniae R6 WT and S. pneumo-
niae R6Δspr0058 (Additional file 3) indeed revealed that
an adjacent operon on the chromosome (spr0059-
spr0065) coding for sugar transporters and metabolizing
enzymes is overexpressed upon inactivation of spr0058
(Additional file 4). Additional putative operons also had
Table 3 The role of mutations detected in R6-SOCPR in resistance to phage SOCP
Strainsa Allelesb EOPc
spr0058 spr0093 spr0897 spr1191 srp1443 spr1584 spr1777 spr1923 (SOCP)
R6 WT WT WT WT WT WT WT WT 1
R6smR WT WT WT WT WT WT WT WT 1
R6-SOCPR R R R R R R R R 10−9
R6spr0058 R WT WT WT WT WT WT WT 10−3
R6Δspr0058 noned WT WT WT WT WT WT WT 10−3
R6spr0093 WT R WT WT WT WT WT WT 1
R6spr0897 WT WT R WT WT WT WT WT 10−3
R6spr1191 WT WT WT R WT WT WT WT 1
R6spr1443 WT WT WT WT R WT WT WT 10−3
R6spr1584 WT WT WT WT WT R WT WT 1
R6spr1777 WT WT WT WT WT WT R WT 1
R6spr1923 WT WT WT WT WT WT WT R 1
R6spr0058-0897 R WT R WT WT WT WT WT 10−9
R6spr0058-1443 R WT WT WT R WT WT WT 10−9
R6spr0897-1443 WT WT R WT R WT WT WT 10−9
R6spr0058-0897-1443 R WT R WT R WT WT WT 10−9
R6-SOCPR_spr0058WT WT R R R R R R R 10−6
R6-SOCPR_spr0093WT R WT R R R R R R 1
R6-SOCPR_spr0897WT R R WT R R R R R 10−6
R6-SOCPR_spr1191WT R R R WT R R R R 1
R6-SOCPR_spr1443WT R R R R WT R R R 10−6
R6-SOCPR_spr1584WT R R R R R WT R R 1
R6-SOCPR_spr1777WT R R R R R R WT R 1
R6-SOCPR_spr1923WT R R R R R R R WT 1
aR6smR integrated an rpsL allele conferring resistance to streptomycin (smR). Each mutated and WT alleles presented in the table was co-transformed with this rpsL
allele that was used as a surrogate marker for the selection of transformants (see Methods). Although not indicated, every transformants in Table 3 are smR
bWT, S. pneumoniae R6 WT gene sequence; R, S. pneumoniae R6-SOCPR gene sequence
cEOP, efficiency of plaquing. Represents the ratio of phage titers from the test strain to the indicator strain R6 WT. Measured from three independent triplicates
dThe gene spr0058 has been inactivated by insertion-duplication mutagenesis in this strain
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their expression altered in S. pneumoniae R6Δspr0058, in-
cluding several carbohydrate transport systems, which are
also likely part of the spr0058 regulon (Additional file 4).
Mutations involved in resistance to Dp-1
Whole genome sequencing of S. pneumoniae R6-DP1R
revealed a total of five mutations, three of which oc-
curred within open reading frames (Table 2). Resistance
reconstruction further confirmed two nucleotide muta-
tions targeting the same codon and leading to a single
amino acid substitution in the McrB subunit of the
McrBC restriction endonuclease (spr1130) (Table 2)
were solely responsible for the high-level resistance of
R6-DP1R (Table 4). Indeed, pneumophage Dp-1 had the
same EOP on R6-DP1R than on S. pneumoniae R6spr1130,
a S. pneumoniae R6 WT derivative into which a spr1130
PCR fragment amplified from R6-DP1R was introduced
(Table 4). Conversely, reverting spr1130 to a WT version
in R6-DP1R completely abrogated its resistance against
pneumophage Dp-1 (R6-DP1R_spr1130WT in Table 4),
confirming the role of the mutation in the phage resist-
ance phenotype. Testing for additional S. pneumoniae
R6 mutants made resistant to Dp-1 again revealed that
three out of the four additional mutants had the same
mutation as R6-DP1R (Table 5), although this time we
cannot exclude that the same clone had been selected
multiple times from the original culture.
Discussion and conclusion
Bacteria have evolved diverse antiviral strategies to survive
in phage-containing environments. These include adsorp-
tion resistance, which results in reduced interactions
between the phage and its bacterium host; restriction-
modification mechanisms and CRISPR-Cas systems,
where bacteria survive and phage genomes are cleaved;
and abortive infections, where bacteria die and phages
usually remain trapped inside (reviewed in [42]). Also,
many steps of the phage replication cycle likely de-
pend on bacterial gene products, which if mutated
may lead to phage resistance. Additional phage defence
systems include superinfection exclusion whereby immun-
ity occurs through the expression of a protein blocking
the entry of DNA for specific phages. The genes encoding
these proteins are often found in prophages, suggesting
that in many cases these systems are important for
phage–phage interactions rather than phage–host interac-
tions (reviewed in [42]).
The genomic characterization of a S. pneumoniae R6
mutant insensitive to phage SOCP revealed mutations in
genes spr0058, spr0897 and spr1443 that seemingly work
additively to increase resistance. The gene spr0058 is
Table 4 The role of mutations detected in R6-DP1R in resistance
to phage Dp-1
Strainsa Allelesb EOPc
spr0290 spr1130 spr1445 spr1453 (Dp-1)
R6 WT WT WT WT 1
R6smR WT WT WT WT 1
R6-DP1R R R R R 10−8
R6spr1130 WT R WT WT 10−8
R6spr1445 WT WT R WT 1
R6-DP1R-spr1130WT R WT R R 1
aR6smR integrated an rpsL allele conferring resistance to streptomycin (smR).
Each mutated and WT alleles presented in the table was co-transformed with
this rpsL allele that was used as a surrogate marker for the selection of
transformants (see Methods). Although not indicated, every transformants
in Table 4 are smR
bWT, S. pneumoniae R6 WT gene sequence; R, S. pneumoniae R6-DP1R
gene sequence
cEOP, efficiency of plaquing. Represents the ratio of phage titers from the test
strain to the indicator strain R6 WT. Measured from three independent triplicate
Table 5 Targeted screening for mutations in additional
bacteriophage insensitive mutants
Strainsa Allelesb,c
spr0058 spr0897 spr1130 spr1443
R6-SOCPR G460A C484A NA T1223C
E154K P162T V408A
R6-SOCP-2R no mutation no mutation NA no mutation
R6-SOCP-3R no mutation C485T NA T1223C
P162L V408A
R6-SOCP-4R C393A no mutation NA T1223C
stop V408A
R6-SOCP-5R no mutation no mutation NA T1223C
V408A
R6-DP1R NA NA T985Gd NA
G986Cd
C329A
R6-DP1-2R NA NA T985Gd NA
G986Cd
C329A
R6-DP1-3R NA NA T985Gd NA
G986Cd
C329A
R6-DP1-4R NA NA no mutation NA
R6-DP1-5R NA NA T985Gd NA
G986Cd
C329A
aFive different mutants had initially been obtained from the same S.
pneumoniae R6 parental culture for the selection of mutants insensitive to the
phages SOCP or Dp-1
bFor each mutation, the change at the nucleotide level is indicated on top and
the corresponding substitution at the amino acid level is indicated in
italic underneath
cNA, not applicable. These alleles were not sequenced because they should be
irrelevant to the resistance phenotype of the phage
dBoth mutated positions are part of the same codon and lead to a single
amino acid substitution
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coding for a transcriptional regulator of the GntR family
and suffered from a G460A mutation leading to an E154K
substitution in S. pneumoniae R6-SOCPR (Table 2). GntR
regulators are one of the most abundant and widely dis-
tributed groups of helix-turn-helix transcription factors
[41]. They contain a DNA-binding domain at their N-
terminus as well as an effector-binding and oligomerisa-
tion domain at the C-terminus of the protein in which the
E154K mutation is located. The effector-binding domain
is believed to modulate activity of bacterial transcription
factors in response to binding small molecules [43]. The
inactivation of spr0058 in R6Δspr0058 conferred the same
SOCP resistance phenotype as the E154K mutation alone
(Table 3) and it is tempting to speculate that the activity
of the GntR regulator is also greatly impaired in the R6-
SOCPR mutant. Inactivation of GntR regulators through
the acquisition of mutations was similarly shown to occur
during adaption of Comamonas testosteroni to utilize phe-
nol as the major carbon source, whereby several different
missense mutations inactivated the repressor activity of
the GntR regulator AphS [44]. GntR regulators bind DNA
as dimers through interaction between their C-terminal
domain [45] and one possibility is that the spr0058 muta-
tion in R6-SOCPR prevents repression by impairing with
dimerization of the regulator at the operator-binding site.
Another possibility would be that the mutation locks the
repressor in a conformation mimicking the presence of
bond ligand, thereby alleviating repression.
GntR family regulators often regulate (e.g. repress)
the expression of neighbor genes [41] and the in-
creased expression in R6Δspr0058 of adjacent genes
spr0059-65 coding for sugar transporters and metab-
olizing enzymes is consistent with this assumption.
Bacterial operons coding for carbohydrate transporters
constitute functional units and, in addition to the
transporter, they are usually coding for glycosyl-
hydrolases for the production of mono- or disaccha-
rides and/or enzymes for the metabolic steps linking
specific sugars to glycolysis [46]. In the case of the spr0059-
65 operon overexpressed in R6Δspr0058 (Additional file 4),
the beta-galactosidase encoded by spr0059 was char-
acterized as a surface enzyme responsible for cleavage
of Galβ1-3GlcNac [47, 48] and it was proposed that
the operon may thus code for a galactose uptake system
[46]. Increased content of galactose in cell wall polymers
have been correlated with increased bacteriophage resist-
ance in Lactococcus lactis subsp. cremoris [49] and Rhizo-
bium meliloti [50, 51]. In the case of phage-resistant L.
lactis subsp. cremoris, an increase in galactosyl-containing
lipoteichoic acid in the cell wall was further linked to a re-
duced bacteriophage adsorption [52]. Teichoic acid is also
involved in pneumophage adsorption [53] and a similar
phenomenon could possibly explain the reduced adsorption
of SOCP on S. pneumoniae R6-SOCPR. The expression of
many other genes (and operons) was altered in R6Δspr0058
besides spr0059-65 however (Additional file 4), and pin-
pointing the gene(s) actually implicated in resistance to
SOCP will required further investigation.
The gene spr0897 mutated in R6-SOCPR (Table 2)
codes for a plasma membrane glycerophosphoryl diester
phosphodiesterase (EC 3.1.4.46), an enzyme of the gly-
cerophospholipid metabolism pathway involved in the
production of glycerol-3-phosphate along with choline
or ethanolamine from glycerophosphocholine or glycer-
ophosphoethanolamine, respectively [54]. The P162T
substitution in R6-SOCPR is located at a conserved pos-
ition within the second extracellular loop based on
TMHMM transmembrane domains prediction. Most
studies on glycerophosphoryl diester phosphodiesterases
have focused on the catalytic domain which is located
away from the P162T mutation at the C-terminus of the
protein and the role of the mutation on the activity of
the protein remains to be further explored. Given the
role of these enzymes in the production of choline [55]
and the dependency of pneumophage adsorption on
choline-containing teichoic acid in the bacterial cell wall
[53], it is possible that the mutation either interferes
with the function of the protein or that it is favoring gly-
cerophosphoethanolamine over glycerophosphocholine
as its preferred substrate. In both cases this would trans-
late into a decreased choline content (and also most
likely of choline-binding proteins) in the cell wall, pos-
sibly explaining the decreased adsorption of SOCP on
R6-SOCPR (Fig. 2). However, glycerophosphoryl diester
phosphodiesterases have been shown to influence gene
expression [56] and an indirect role for the mutation in
resistance by altering gene expression in R6-SOCPR can-
not be ruled out.
The last mutation implicated in resistance against bac-
teriophage SOCP in R6-SOCPR occurred in gene spr1443
(Table 2) coding for a Mur ligase homolog named MurT
[57–59]. MurT, along with the product of gene spr1444
(GatD), was recently shown to be responsible for the ami-
dation of the glutamate residue in position 2 of the stem
peptide of lipid II, a peptidoglycan precursor [57–59]. Ami-
dation of lipid II is required for efficient peptidoglycan
cross-linking in some Gram positive bacteria, including S.
pneumoniae, and non-amidated glutamate-containing pep-
tides were indeed found to be scarce in S. pneumoniae
[60]. Cell wall cross-linking is important for optimal
growth and influences susceptibility to antibiotics and mu-
rein hydrolases [57, 58]. The MurT V408A substitution
detected in R6-SOCPR is located at the C-terminus of the
protein in a domain named DUF1727. This domain of un-
known function is associated with the C-terminus of bac-
terial Mur ligases (http://pfam.xfam.org/family/PF08353).
The role of the V408A substitution on the activity of
MurT/GatD remains to be established but is unlikely to
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inactivate the activity of this amido transferase system
which was shown to be essential in S. aureus [57, 58] and
S. pneumoniae R6 [59].
Resistance to bacteriophage Dp-1 involved a single
mutation in the gene spr1130 coding for the McrB
subunit of a type IV McrBC restriction endonuclease
(Tables 2 and 5). Type IV restriction endonucleases
recognize modified, typically methylated, DNA. The
McrBC endonucleases recognize and cleave DNA
containing two hemi or fully methylated RmC sites in
an optimal distance of about 40 to 80 base pairs [61].
The nuclease active site of the McrBC restriction
endonuclease resides in its McrC subunit [62] while
McrB is responsible for DNA binding and GTP hy-
drolysis [63, 64]. The C330A mutation in R6-DP1R is
not in the McrB domain responsible for recognition
of methylated DNA which was shown to reside in the
first 161 residues of the protein [65, 66]. The muta-
tion is instead located in the GTPase domain located
at the C-terminus of McrB, in a region conserved be-
tween several McrB sequences [67]. Interestingly, tar-
geted mutagenesis of conserved polar amino acids to
an alanine residue within the conserved region in
Escherichia coli translated into an array of phenotypes
going from complete inactivation to impaired GTP or
DNA binding and even enhanced GTPase activity
[67]. The equivalent residue to C330 in R6-DP1R was
not part of the sites targeted by the mutagenesis how-
ever and it is not possible to infer about a possible
phenotype at the moment. Still, the Dp-1 genome is
resistant to several type II restriction enzymes, sug-
gesting the presence of modified bases, and it will be
interesting to further study the impact of the mutated
version of McrBC on Dp-1 DNA.
Finally, every lytic pneumophage studied to date (the
omega phages in [27] and the SOCP and Dp-1 phages
herein) are inhibited by the pneumococcal capsule and it
is puzzling how these phages can thrive in natural set-
tings among encapsulated clinical isolates. Many encap-
sulated pneumococcal strains also carry prophages and
were thus infected by phages at some point [19–21]. On
the other hand, pneumococcal strains that lack a capsule
have been isolated from conjunctivitis cases [68]. The
conversion between encapsulated and unencapsulated
states is not uncommon in S. pneumoniae however and
may be an important factor in population dynamics [69]
and favor phage infection. Alternatively, the nasophar-
ynx is host to the related Streptococcus mitis which was
shown to support the replication of pneumophages, at
least in the case of SOCP and Dp-1 [25]. Interestingly,
non-typeable strains of S. pneumoniae (which include
those lacking a capsule) were shown to have significantly
higher probabilities to act as DNA donor in DNA re-
combination events compared to strains with well-
defined capsule types [70]. Whether this is due to
phage-mediated lysis is not known but it is worrying that
non-typeable strains of S. pneumoniae also appear to be
highly enriched in antibiotic resistance alleles [71]. It
might thus be worth assessing whether sensitivity to lytic
phages makes unencapsulated (non-typeable) strains a
potential major reservoir to enhance the flow of resist-
ance genes.
In conclusion, this study reported on the use of whole
genome sequencing to expedite the identification of
novel pneumococcal genes involved in phage-host inter-
actions. It also suggested that different host factors are
involved in the replication of phages belonging to differ-
ent phage families.
Methods
Amplification, phage titer and adsorption of SOCP and Dp-1
Pneumophages SOCP [25] and Dp-1 [12] were ob-
tained from the Félix d’Hérelle Reference Center for
Bacterial Viruses (www.phage.ulaval.ca). Amplification
and purification of bacteriophages was done on S.
pneumoniae R6 WT as previously described for SOCP
[25] and Dp-1 [23]. Phage titers were determined on
S. pneumoniae grown in filtrated BHI+ (BHI medium
supplemented with 0.25 mM CaCl2, 0.2 mM MgCl2,
8.0 μM MnCl2, 5 ng/mL of choline chloride and 50
mM Tris pH 7.5) at 35 °C in a 5 % CO2 atmosphere.
When cell growth reached an OD600 of 0.12 a volume
of 2 mL was taken and spread on agarose plates pre-
pared by mixing equal volumes of 1 % agarose and
2× filtrated BHI+ supplemented with 50 μg ml−1 cata-
lase and 0.4 % of glycine. Plates were left to stand for
5 min before the excess liquid was drained and left to
dry for 10 min. Purified SOCP and Dp-1 were serially
diluted in BHI and 5 μL was spotted on the bacterial
top and left to dry for 10 min. The plates were incubated
overnight at 35 °C under a 5 % CO2 atmosphere. Plaques
were counted, and the phage titer was determined. EOP
was calculated by dividing the phage titer (in plaque form-
ing units (PFU) per mL) on the test strain by the phage
titer in PFU per mL on the S. pneumoniae R6 WT indica-
tor strain. Adsorption of bacteriophages SCOP1 and Dp-1
was determining from independent triplicates as previ-
ously described [25].
Isolation of S. pneumoniae R6 bacteriophage insensitive
mutants
S. pneumoniae R6 was grown in BHI+ supplemented
with 0.4 % glycine to an OD600 of 0.4 under a 5 % CO2
atmosphere at 35 °C. A 1 mL aliquot was mixed with
100 uL of purified SOCP or Dp-1 (109 PFU, multiplicity
of infection of 10) and 50 μg/mL of catalase. After a 10
min incubation, the mixture was embedded in 10 mL of
0.7 % low melting point agarose in BHI+ supplemented
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with 0.4 % glycine. This top agarose was poured onto a
1 % BHI+ bottom agar supplemented with 0.4 % glycine
and incubated overnight at 35 °C under a 5 % CO2 at-
mosphere. Seven and six colonies resistant to Dp-1 and
SOCP were obtained, respectively. Resistant colonies
were picked out using a sterile toothpick, spread a few
times on TSA blood agar and confirmed for phage resist-
ance as described above. All clones had similar levels of
resistance to the phage used for their selection and two re-
sistant clones (one for Dp-1 and another for SOCP) were
randomly chosen for whole-genome sequencing.
Whole genome sequencing
Genomic DNA was extracted from mutants S. pneumo-
niae R6-SOCPR and R6-DP1R using the Wizard Genomic
DNA Purification Kit (Promega) according to the manu-
facturer’s instructions. Whole genome sequencing was
performed using a 454 Life Sciences GS-FLX system
(Roche). Genome sequencing, assemblies and comparative
analyses were performed at the Institute for Integrative
Systems Biology of Université Laval. Both assemblies cov-
ered >99 % of the S. pneumoniae R6 reference genome
with a mean coverage depth of 53-fold and 47-fold for R6-
DP1R and R6-SOCPR, respectively. The detection of single
nucleotide polymorphisms was performed using samtools
(version 0.1.18), bcftools (distributed with samtools) and
vcfutils.pl (distributed with samtools) [72]. All mutations
deduced from massively parallel sequencing had at least
25-fold coverage and were confirmed by PCR amplifica-
tion and conventional DNA sequencing. The sequencing
reads are available on the Sequence Read Archive database
under the study number PRJEB9347 and sample accession
ERS719580 and ERS7195801 for R6-DP1R and R6-SOCPR,
respectively.
RNA sequencing
Total RNA was isolated from S. pneumoniae R6Δspr0058
and R6 WT grown to mid-log phase in BHI using the
Qiagen RNeasy Mini Kit (Qiagen) according to the manu-
facturer’s instructions. RNAs were quantified using 2100
BioAnalyzer RNA6000 Nano chips (Agilent) and 1 μg of
total RNA was treated with Ribo-Zero™ rRNA Removal
Kits (Epicentre). RNA-seq libraries were produced from
50 ng of rRNA-depleted samples using the ScriptSeq™ v2
RNA-Seq Library Preparation Kit (Epicentre). The librar-
ies were analyzed using 2100 BioAnalyser High Sensitivity
DNA chips and quantified by PicoGreen. The libraries
were pooled, diluted to 8 pM and sequenced on an Illu-
mina MiSeq system using a 250 bp paired-ends reads
protocol. Sequence reads from each strain were filtered
based on quality score using Trimmomatic [73] and
aligned to the genome of S. pneumoniae R6 using the soft-
ware bwa with default parameters [74]. A total of 3,843,210
and 3,245,555 reads derived from S. pneumoniae R6 WT
and R6Δspr0058 mapped to the S. pneumoniae R6 refer-
ence genome, respectively. The maximum number of
mismatches was 4 and the seed length was 32. Tran-
scripts were assembled from the alignment files by
using the Cufflinks pipeline [75]. Differential gene ex-
pression was computed with CuffDiff and genes with a
false-discovery rate-adjusted p-value ≤ 0.05 were con-
sidered as differentially expressed.
DNA transformation and gene inactivation
PCR fragments containing the mutations of interest
were amplified using the Phusion High-Fidelity Poly-
merase (NEB) and primers listed in Additional file 5 at
a final concentration of 0.5μM. DNA fragments were
amplified by 35 PCR cycles each made of 10 s denatur-
ation, 20 s annealing and 30 s (for short 500bp PCR
fragments) or 3 min (for long PCR fragments of 5kb)
polymerisation (with an initial denaturation of 2 min and
a final extension of 10 min). PCR fragments were purified
using the QIAquick PCR purification kit (QIAGEN).
PCR fragments were co-transformed in S. pneumoniae
competent cells along with 100ng of a short rpsL
PCR fragment (500bp) amplified from S. pneumoniae
CP1250 [40]. This co-transformed fragment is coding
for a ribosomal protein S12 variant (Lys57Thr) con-
ferring resistance to streptomycin that was used as a
surrogate marker for the selection of transformants as
previously described [35]. Competent cells were ob-
tained by the dilution of an overnight S. pneumoniae
culture 1:100 in C + Y medium, pH 6.8 (ref 47 FF).
The diluted cultures were grown up to the onset of
exponential phase before being concentrated ten times
and frozen in C + Y, pH 6.8, 15 % glycerol. For trans-
formation, competent cells were thawed on ice, di-
luted ten times with C + Y medium, pH 7.8, and
complemented with 2 μg/mL of competence stimulating
peptide 1 before being incubated for 15 min at 35 °C
under a 5 % CO2 atmosphere. DNA was added to a final
concentration of 2 μg/mL and the cultures were incubated
for 1 h at 30 °C. Finally, the cultures were switched
to 35 °C under a 5 % CO2 atmosphere for 1 h before
being plated on CAT agar supplemented with 150μg/mL
streptomycin. The plates were incubated for 48 h at 35 °C
under a 5 % CO2 atmosphere and the resistant colonies
were picked for further studies. Inactivation of spr0058 by
insertional duplication mutagenesis in S. pneumoniae R6
was performed by cloning the middle section of spr0058
(using primers listed in Additional file 5) into the nonre-
plicative vector pFF6 as previously described [35]. The
resulting plasmid was transformed into S. pneumoniae R6
as described above (without the need for rpsL co-
transformation) and transformants were selected on CAT
agar supplemented with 600μg/mL kanamycin.
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Replication of SOCP and Dp-1
S. pneumoniae R6 was infected with SOCP or Dp-1 at a
MOI of 0.1. Total DNA (i.e. S. pneumoniae genomic DNA
together with phage DNA) was isolated at different time
points after infection using the Wizard® Genomic DNA
Purification kit (Promega) following manufacturer’s
instructions. Extracted DNA was digested with SspI,
size-separated by electrophoresis, transferred to Nylon
membrane and hybridized with [α-32P]dCTP-labeled
probes according to standard protocols [76]. Probes were
obtained by PCR amplification of the holin gene from
phage SOCP or Dp-1 and from the S. pneumoniae gene
spr1443 using primers listed in Additional file 5.
Electron microscopy
Pneumococci were grown in BHI to an OD of 0.2. Cells
were washed in 1× PBS, suspended in fixation buffer (0.1
M Cacodylate pH7.4, 2 % glutaraldehyde) and incubated
at 4 °C overnight. Specimen were prepared and analyzed
using standard procedure by the Plate-forme d’Imagerie
Moléculaire & Microscopie of the Institute for Integrative
Systems Biology of Université Laval using a Transmission
Electron Microscope model JEOL 1010 at 100000× magni-
fication. For each sample, cell wall thickness was measured
from 30 bacteria (2 measures per bacteria) using ImageJ.
Quellung reaction
Quellung reaction was performed using pneumococcal
type 2 antisera from the Statens Serum Institute as de-
scribed in manufacturer’s protocol. Samples were visua-
lised under oil immersion using a Nikon Eclipse TE300
microscope and a 100× objective.
Availability of supporting data
Sequencing reads have been deposited at the EBI SRA
database under the study accession number PRJEB9347.
Additional files
Additional file 1: Figure S1. Growth kinetics of S. pneumoniae R6 WT,
R6-DP1R and R6-SOCPR. The growth of S. pneumoniae R6 WT (black
dashed line), R6-DP1R (light grey line) and R6-SOCPR (dark grey line) in
BHI was monitored at one hour intervals for a period of 11 h. Data are
expressed as the mean of three independent experiments. (TIFF 122 kb)
Additional file 2: Figure S2. Cell wall thickness of S. pneumoniae R6
WT, R6-SOCPR and R6-DP1R. Electron micrographs of S. pneumoniae R6
WT (A), R6-SOCPR (B) and R6-DP1R (C) at 100000× magnification. (D)
Mean cell wall thickness for S. pneumoniae R6 WT (black), R6-SOCPR
(light grey) and R6-DP1R (dark grey) measured from 30 bacteria with
two measurements per bacteria. (TIFF 4146 kb)
Additional file 3: Figure S3. Gene expression profiling in S. pneumoniae
R6Δspr0058. Gene expression was compared between S. pneumoniae R6 WT
and R6Δspr0058 by RNA-seq. The dots represent the 2043 genes from the S.
pneumoniae R6 genome and their level of expression in R6 WT and
R6Δspr0058 (represented in terms of fragments per kilobase of transcript per
million fragments mapped) is indicated on the x- and y-axis, respectively.
(TIFF 151 kb)
Additional file 4. Genes with an altered expression upon
inactivation of spr0058 as determined by RNAseq. (PDF 128 kb)
Additional file 5. PCR primers used in this study. (PDF 23 kb)
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